• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.82% Nasdaq Up0.73%

    Ligand Pharmaceuticals Incorporated (LGND)

    89.41 Up 4.75(5.61%) 10:58AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Ligand Pharmaceuticals Incorporated
    11119 North Torrey Pines Road
    Suite 200
    La Jolla, CA 92037
    United States - Map
    Phone: 858-550-7500
    Website: http://www.ligand.com

    Index Membership:N/A
    Full Time Employees:19

    Business Summary 

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for the treatment of multiple myeloma; bazedoxifene, which is used for the treatment of postmenopausal osteoporosis; and Captisol-enabled Noxafil-IV, a formulation of posaconazole for intravenous (IV) use. Its late-stage development programs include Captisol-enabled Melphalan IV, MK-8931 Beta-Secretase Inhibitor, Captisol-enabled SAGE-547, Sparsentan, Captisol-enabled Delafloxacin-IV, Captisol-enabled Carbamazepine-IV, IRAK4 Inhibitor Program, LTP Technology with Omega-3 Fatty Acids, Biologic Therapeutics Platform, Captisol-enabled Topiramate IV, Lasofoxifene, and Captisol-enabled Lamotrigine IV. The company’s internal product development programs include Glucagon Receptor Antagonist Program, Oral Human Granulocyte Colony Stimulating Factor Program, LTP Platform, Kinase Inhibitors, HepDirect HCV Inhibitor Program, and other programs. Its therapies in development portfolio addresses the unmet medical needs of patients for a range of diseases, including hepatitis, multiple myeloma, muscle wasting, Alzheimer’s disease, dyslipidemia, diabetes, anemia, epilepsy, focal segmental glomerulosclerosis, and osteoporosis. Ligand Pharmaceuticals Incorporated has alliances with GlaxoSmithKline, Amgen, Inc., Merck, Pfizer, Baxter International, and Eli Lilly and Co. The company was founded in 1987 and is headquartered in La Jolla, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Ligand Pharmaceuticals Incorporated

    Corporate Governance 
    Ligand Pharmaceuticals Incorporated’s ISS Governance QuickScore as of May 1, 2015 is 7. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 7; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. John L. Higgins , 45
    Chief Exec. Officer and Exec. Director
    Mr. Matthew W. Foehr , 42
    Pres and Chief Operating Officer
    Mr. Charles S. Berkman J.D., 46
    VP, Gen. Counsel and Sec.
    Ms. Melanie J. Herman , 36
    Interim Chief Financial Officer, Chief Accounting Officer and Director of Accounting
    Rob McKay ,
    Sr. Director of Bus. Devel. and Investor Relations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders